CRON
Cronos Group Inc.
Drug Manufacturers - Specialty & Generic
Market Cap$981M
5Y Perf.-60.6%
Compare Stocks
2 / 10Try these comparisons:
Stock Comparison
CRON vs IIPR
Revenue, margins, valuation, and 5-year total return — side by side.
IIPR
Innovative Industrial Properties, Inc.
REIT - Industrial
Market Cap$1.62B
5Y Perf.-30.7%
CRON vs IIPR — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | CRON | IIPR |
|---|---|---|
| Industry | Drug Manufacturers - Specialty & Generic | REIT - Industrial |
| Market Cap | $981M | $1.62B |
| Revenue (TTM) | $193M | $263M |
| Net Income (TTM) | $-9M | $120M |
| Gross Margin | 32.5% | 60.3% |
| Operating Margin | -1.5% | 46.7% |
| Forward P/E | 34.3x | 13.2x |
| Total Debt | $2M | $394M |
| Cash & Equiv. | $792M | $48M |
CRON vs IIPR — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
CRON
IIPR
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Cronos Group Inc. (CRON) | 100 | 39.4 | -60.6% |
| Innovative Industri… (IIPR) | 100 | 69.3 | -30.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CRON vs IIPR
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: IIPR leads in 5 of 7 categories, making it the strongest pick for valuation and capital efficiency and profitability and margin quality. Cronos Group Inc. is the stronger pick specifically for growth and revenue expansion and recent price momentum and sentiment. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
CRON
Cronos Group Inc.
The Growth Play
CRON is the clearest fit if your priority is growth exposure and long-term compounding.
- Rev growth 64.4%, EPS growth -100.0%, 3Y rev CAGR 30.6%
- 14.6% 10Y total return vs IIPR's 436.4%
- Lower volatility, beta 0.98, Low D/E 0.1%, current ratio 19.59x
Best for: growth exposure and long-term compounding
IIPR
Innovative Industrial Properties, Inc.
The Real Estate Income Play
IIPR carries the broadest edge in this set and is the clearest fit for income & stability and defensive.
- Dividend streak 9 yrs, beta 0.92, yield 13.5%
- Beta 0.92, yield 13.5%, current ratio 0.15x
- Lower P/E (13.2x vs 34.3x)
Best for: income & stability and defensive
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | CRON | 64.4% revenue growth vs IIPR's -13.8% |
| Value | IIPR | Lower P/E (13.2x vs 34.3x) |
| Quality / Margins | IIPR | 45.6% margin vs CRON's -4.9% |
| Stability / Safety | IIPR | Beta 0.92 vs CRON's 0.98 |
| Dividends | IIPR | 13.5% yield; 9-year raise streak; the other pay no meaningful dividend |
| Momentum (1Y) | CRON | +38.9% vs IIPR's +20.3% |
| Efficiency (ROA) | IIPR | 5.1% ROA vs CRON's -0.8%, ROIC 4.3% vs -0.8% |
CRON vs IIPR — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FY 2025
Segment breakdown not available.
CRON vs IIPR — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLIIPRLAGGINGCRON
CRONCronos Group Inc.
1leads
IIPRInnovative Industrial…
3leads
6 Total Categories
CATEGORYLEADERvs CRONMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
IIPR5/6
Valuation MetricsMultiples, price ratios, and targets
IIPR2/3
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
Tied
—
Total Returns1Y, 3Y, 5Y total returns with dividends
CRON4/6
Risk & VolatilityBeta, volatility, and downside exposure
IIPR2/2
Analyst OutlookRatings, price targets, and dividends
—
—
Income & Cash Flow (Last 12 Months)
IIPR leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
IIPR and CRON operate at a comparable scale, with $263M and $193M in trailing revenue. IIPR is the more profitable business, keeping 45.6% of every revenue dollar as net income compared to CRON's -4.9%. On growth, CRON holds the edge at +2.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | CRONCronos Group Inc. | IIPRInnovative Indust… |
|---|---|---|
| RevenueTrailing 12 months | $193M | $263M |
| EBITDAEarnings before interest/tax | -$810,000 | $197M |
| Net IncomeAfter-tax profit | -$9M | $120M |
| Free Cash FlowCash after capex | -$163,766 | $144M |
| Gross MarginGross profit ÷ Revenue | +32.5% | +60.3% |
| Operating MarginEBIT ÷ Revenue | -1.5% | +46.7% |
| Net MarginNet income ÷ Revenue | -4.9% | +45.6% |
| FCF MarginFCF ÷ Revenue | -0.1% | +54.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | +2.0% | -3.8% |
| EPS Growth (YoY)Latest quarter vs prior year | -100.0% | -1.0% |
IIPR leads this category, winning 5 of 6 comparable metrics.
Valuation Metrics
IIPR leads this category, winning 2 of 3 comparable metrics.
Valuation Metrics
| Metric | CRONCronos Group Inc. | IIPRInnovative Indust… |
|---|---|---|
| Market CapShares × price | $981M | $1.6B |
| Enterprise ValueMkt cap + debt − cash | $190M | $2.0B |
| Trailing P/EPrice ÷ TTM EPS | — | 14.40x |
| Forward P/EPrice ÷ next-FY EPS est. | 34.27x | 13.17x |
| PEG RatioP/E ÷ EPS growth rate | — | 3.85x |
| EV / EBITDAEnterprise value multiple | — | 9.91x |
| Price / SalesMarket cap ÷ Revenue | 5.07x | 6.08x |
| Price / BookPrice ÷ Book value/share | 0.90x | 0.87x |
| Price / FCFMarket cap ÷ FCF | — | 9.26x |
IIPR leads this category, winning 2 of 3 comparable metrics.
Profitability & Efficiency
Evenly matched — CRON and IIPR each lead in 4 of 8 comparable metrics.
Profitability & Efficiency
IIPR delivers a 6.4% return on equity — every $100 of shareholder capital generates $6 in annual profit, vs $-1 for CRON. CRON carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to IIPR's 0.21x. On the Piotroski fundamental quality scale (0–9), CRON scores 6/9 vs IIPR's 4/9, reflecting solid financial health.
| Metric | CRONCronos Group Inc. | IIPRInnovative Indust… |
|---|---|---|
| ROE (TTM)Return on equity | -0.9% | +6.4% |
| ROA (TTM)Return on assets | -0.8% | +5.1% |
| ROICReturn on invested capital | -0.8% | +4.3% |
| ROCEReturn on capital employed | -0.3% | +5.8% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 4 |
| Debt / EquityFinancial leverage | 0.00x | 0.21x |
| Net DebtTotal debt minus cash | -$790M | $346M |
| Cash & Equiv.Liquid assets | $792M | $48M |
| Total DebtShort + long-term debt | $2M | $394M |
| Interest CoverageEBIT ÷ Interest expense | — | 6.67x |
Evenly matched — CRON and IIPR each lead in 4 of 8 comparable metrics.
Total Returns (Dividends Reinvested)
CRON leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in IIPR five years ago would be worth $4,999 today (with dividends reinvested), compared to $3,342 for CRON. Over the past 12 months, CRON leads with a +38.9% total return vs IIPR's +20.3%. The 3-year compound annual growth rate (CAGR) favors CRON at 8.9% vs IIPR's 4.5% — a key indicator of consistent wealth creation.
| Metric | CRONCronos Group Inc. | IIPRInnovative Indust… |
|---|---|---|
| YTD ReturnYear-to-date | -4.8% | +18.3% |
| 1-Year ReturnPast 12 months | +38.9% | +20.3% |
| 3-Year ReturnCumulative with dividends | +29.1% | +14.1% |
| 5-Year ReturnCumulative with dividends | -66.6% | -50.0% |
| 10-Year ReturnCumulative with dividends | +1457.6% | +436.4% |
| CAGR (3Y)Annualised 3-year return | +8.9% | +4.5% |
CRON leads this category, winning 4 of 6 comparable metrics.
Risk & Volatility
IIPR leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
IIPR is the less volatile stock with a 0.92 beta — it tends to amplify market swings less than CRON's 0.98 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. IIPR currently trades 92.2% from its 52-week high vs CRON's 74.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | CRONCronos Group Inc. | IIPRInnovative Indust… |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.98x | 0.92x |
| 52-Week HighHighest price in past year | $3.43 | $61.40 |
| 52-Week LowLowest price in past year | $1.84 | $44.58 |
| % of 52W HighCurrent price vs 52-week peak | +74.9% | +92.2% |
| RSI (14)Momentum oscillator 0–100 | 49.3 | 59.3 |
| Avg Volume (50D)Average daily shares traded | 1.4M | 303K |
IIPR leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates CRON as "Hold" and IIPR as "Hold". Consensus price targets imply -10.5% upside for CRON (target: $2) vs -22.3% for IIPR (target: $44). IIPR is the only dividend payer here at 13.46% yield — a key consideration for income-focused portfolios.
| Metric | CRONCronos Group Inc. | IIPRInnovative Indust… |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Hold |
| Price TargetConsensus 12-month target | $2.30 | $44.00 |
| # AnalystsCovering analysts | 15 | 11 |
| Dividend YieldAnnual dividend ÷ price | — | +13.5% |
| Dividend StreakConsecutive years of raises | — | 9 |
| Dividend / ShareAnnual DPS | — | $7.62 |
| Buyback YieldShare repurchases ÷ mkt cap | +1.0% | +1.2% |
Insufficient data to determine a leader in this category.
Key Takeaway
IIPR leads in 3 of 6 categories (Income & Cash Flow, Valuation Metrics). CRON leads in 1 (Total Returns). 1 tied.
Best OverallInnovative Industrial Prope… (IIPR)Leads 3 of 6 categories
Loading custom metrics...
CRON vs IIPR: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is CRON or IIPR a better buy right now?
For growth investors, Cronos Group Inc.
(CRON) is the stronger pick with 64. 4% revenue growth year-over-year, versus -13. 8% for Innovative Industrial Properties, Inc. (IIPR). Innovative Industrial Properties, Inc. (IIPR) offers the better valuation at 14. 4x trailing P/E (13. 2x forward), making it the more compelling value choice. Analysts rate Cronos Group Inc. (CRON) a "Hold" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CRON or IIPR?
On forward P/E, Innovative Industrial Properties, Inc.
is actually cheaper at 13. 2x.
03Which is the better long-term investment — CRON or IIPR?
Over the past 5 years, Innovative Industrial Properties, Inc.
(IIPR) delivered a total return of -50. 0%, compared to -66. 6% for Cronos Group Inc. (CRON). Over 10 years, the gap is even starker: CRON returned +1458% versus IIPR's +436. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CRON or IIPR?
By beta (market sensitivity over 5 years), Innovative Industrial Properties, Inc.
(IIPR) is the lower-risk stock at 0. 92β versus Cronos Group Inc. 's 0. 98β — meaning CRON is approximately 7% more volatile than IIPR relative to the S&P 500. On balance sheet safety, Cronos Group Inc. (CRON) carries a lower debt/equity ratio of 0% versus 21% for Innovative Industrial Properties, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — CRON or IIPR?
By revenue growth (latest reported year), Cronos Group Inc.
(CRON) is pulling ahead at 64. 4% versus -13. 8% for Innovative Industrial Properties, Inc. (IIPR). On earnings-per-share growth, the picture is similar: Innovative Industrial Properties, Inc. grew EPS -28. 8% year-over-year, compared to -100. 0% for Cronos Group Inc.. Over a 3-year CAGR, CRON leads at 30. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CRON or IIPR?
Innovative Industrial Properties, Inc.
(IIPR) is the more profitable company, earning 43. 0% net margin versus -4. 9% for Cronos Group Inc. — meaning it keeps 43. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: IIPR leads at 46. 7% versus -1. 5% for CRON. At the gross margin level — before operating expenses — IIPR leads at 88. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CRON or IIPR more undervalued right now?
On forward earnings alone, Innovative Industrial Properties, Inc.
(IIPR) trades at 13. 2x forward P/E versus 34. 3x for Cronos Group Inc. — 21. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CRON: -10. 5% to $2. 30.
08Which pays a better dividend — CRON or IIPR?
In this comparison, IIPR (13.
5% yield) pays a dividend. CRON does not pay a meaningful dividend and should not be held primarily for income.
09Is CRON or IIPR better for a retirement portfolio?
For long-horizon retirement investors, Cronos Group Inc.
(CRON) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 98), +1458% 10Y return). Both have compounded well over 10 years (CRON: +1458%, IIPR: +436. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CRON and IIPR?
These companies operate in different sectors (CRON (Healthcare) and IIPR (Real Estate)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: CRON is a small-cap high-growth stock; IIPR is a small-cap deep-value stock. IIPR pays a dividend while CRON does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
Revenue Growth>
%
(CRON: 201.3% · IIPR: -3.8%)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.